Konkurrenz
| Unternehmen | Börsenwert | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Roche Holding SWX:ROP |
251,72 Mrd. | 1,38 % | 6/6 | 2,95 % | -6,29 % | 10,90 % | UP |
|
Merck NYSE:MRK |
297,40 Mrd. | 7,67 % | 6/6 | -21,36 % | -11,01 % | 9,73 % | UP |
|
Amgen NasdaqGS:AMGN |
189,67 Mrd. | 7,37 % | 3/6 | 2,72 % | -8,77 % | -0,53 % | UP |
|
Novo Nordisk A/S CPSE:NOVO B |
1.025,14 Mrd. | 20,54 % | 5/6 | -8,58 % | 66,88 % | 30,36 % | DOWN |
|
Pfizer NYSE:PFE |
159,73 Mrd. | 7,82 % | 4/6 | -5,31 % | 17,47 % | -3,85 % | UP |
|
Bristol-Myers Squibb NYSE:BMY |
123,83 Mrd. | 1,77 % | 5/6 | -0,30 % | -6,13 % | 5,52 % | UP |
|
Sanofi ENXTPA:SAN |
99,89 Mrd. | 5,21 % | 5/6 | 7,19 % | 13,34 % | 20,89 % | DOWN |
|
Vertex Pharmaceuticals NasdaqGS:VRTX |
113,44 Mrd. | 13,44 % | 6/6 | 6,43 % | -3,67 % | 24,96 % | DOWN |
|
Takeda Pharmaceutical Company TSE:4502 |
8.948,06 Mrd. | 10,31 % | 3/5 | 22,10 % | -30,48 % | 2,40 % | UP |
|
Bayer XTRA:BAYN |
38,69 Mrd. | -1,16 % | 3/6 | -8,53 % | -17,88 % | 32,01 % | UP |
|
Alnylam Pharmaceuticals NasdaqGS:ALNY |
43,88 Mrd. | 46,06 % | 4/6 | 49,91 % | 1,38 % | 36,00 % | DOWN |
|
Daiichi Sankyo Company TSE:4568 |
5.072,29 Mrd. | 17,16 % | 4/5 | 9,69 % | 63,69 % | 71,73 % | DOWN |
|
Biogen NasdaqGS:BIIB |
26,91 Mrd. | -10,57 % | 1/6 | -1,25 % | 4,73 % | 11,00 % | UP |
|
United Therapeutics NasdaqGS:UTHR |
25,99 Mrd. | 15,13 % | 5/6 | 2,41 % | -46,95 % | 7,00 % | UP |
|
Moderna NasdaqGS:MRNA |
20,15 Mrd. | 12,29 % | 2/6 | 22,84 % | -591,49 % | -21,26 % | UP |
|
Incyte NasdaqGS:INCY |
18,74 Mrd. | 41,79 % | 5/6 | 8,74 % | 28,21 % | 13,12 % | UP |
|
Hologic NasdaqGS:HOLX |
16,88 Mrd. | 2,80 % | 5/6 | 3,62 % | -5,38 % | 0,54 % | UP |
|
Viatris NasdaqGS:VTRS |
15,56 Mrd. | -3,69 % | 4/6 | 2,85 % | -38,28 % | 25,83 % | UP |
|
Swedish Orphan Biovitrum AB (publ) OM:SOBI |
135,57 Mrd. | 10,82 % | 5/6 | 3,18 % | -17,56 % | 12,19 % | UP |
|
Neurocrine Biosciences NasdaqGS:NBIX |
13,22 Mrd. | 14,30 % | 4/6 | 22,44 % | 32,56 % | 34,36 % | DOWN |
